![]() |
市場調查報告書
商品編碼
2149073
醫藥玻璃包裝市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。Pharmaceutical Glass Packaging Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
受製藥業擴張、醫療保健支出增加、藥品需求成長以及製藥生產技術進步的推動,全球醫藥玻璃包裝市場正經歷顯著成長。 2025年,全球醫藥玻璃包裝市場規模為242.9億美元,預計2026年將達269.4億美元。到2034年,該市場預計將達到616.3億美元,2026年至2034年的複合年成長率(CAGR)為10.90%。北美地區在2025年佔市場主導地位,市佔率達33.6%。
醫藥玻璃包裝用於保護藥品免受物理損傷、污染、潮濕、空氣和其他外部因素的影響。玻璃具有化學惰性、透明、堅固、可回收和可消毒等優點,因此適用於製造藥瓶、管瓶、安瓿、藥筒和注射器等包裝容器。預計到2034年,藥品、生物製藥、學名藥和注射劑需求的持續成長將推動市場發展。
市場定義和範圍
醫藥玻璃包裝市場涵蓋專為藥品設計的玻璃容器和包裝解決方案。主要產品包括管瓶、安瓿瓶、玻璃瓶、藥筒和注射器。該市場涵蓋用於學名藥、品牌藥和生物製藥的包裝,整體應用於製藥生產和醫療領域。
市場動態
成長要素
全球製藥業的擴張是推動成長要素。醫療保健成本上升、疾病盛行率增加、人口成長以及健康意識的提高,都推動了對藥品需求的成長,進而增加了對藥品包裝的需求。玻璃因其防護性能優異且防潮防空氣的特性而備受青睞。
製藥製造技術的進步也創造了新的機會。先進玻璃配方的開發、生產流程的改進以及包裝技術的進步,使製造商能夠提高產品安全性並最大限度地降低污染風險。
趨勢
採用新型玻璃以最大限度減少藥品污染是重要的市場趨勢。無硼藥用玻璃可提供更均勻的化學性質和更高的化學耐久性。此外,製造商還採用永久性標記和先進包裝等技術來增強產品識別性並解決仿冒品問題。
阻礙因素
替代包裝材料(尤其是塑膠)的日益普及可能會抑制市場成長。塑膠包裝具有輕巧、柔軟性、抗衝擊、易於成型和運輸成本低等優點。此外,與玻璃容器相比,塑膠瓶和塑膠筒還能降低意外破損的風險。
新冠疫情的影響
新冠疫情增加了對疫苗、藥品和其他醫療產品的需求,凸顯了藥品包裝的重要性。隨著製藥公司擴大疫苗和治療藥物的生產,對管瓶、注射器和其他醫用玻璃容器的需求也隨之增加。同時,由於供應鏈中斷和生產限制,包裝製造商面臨許多挑戰。疫情也加速了對藥品生產和包裝能力的投資。
The global pharmaceutical glass packaging market is witnessing significant growth, supported by the expansion of the pharmaceutical industry, increasing healthcare expenditure, rising demand for medicines, and advancements in pharmaceutical manufacturing. The global pharmaceutical glass packaging market size was valued at USD 24.29 billion in 2025 and is projected to grow to USD 26.94 billion in 2026. The market is expected to reach USD 61.63 billion by 2034, exhibiting a CAGR of 10.90% from 2026 to 2034. North America dominated the market with a 33.6% share in 2025.
Pharmaceutical glass packaging is used to protect medicines from physical damage, contamination, moisture, air, and other external influences. Glass offers chemical inertness, transparency, rigidity, recyclability, and sterilization capabilities, making it suitable for pharmaceutical bottles, vials, ampoules, cartridges, and syringes. Increasing demand for pharmaceutical drugs, biologics, generic medicines, and injectable products is expected to support the market through 2034.
Market Definition and Scope
The pharmaceutical glass packaging market covers glass containers and packaging solutions designed specifically for pharmaceutical products. Major products include vials and ampoules, bottles, cartridges, and syringes. The market encompasses packaging used for generic, branded, and biologic drugs across pharmaceutical manufacturing and healthcare applications.
Market Dynamics
Drivers
The global expansion of the pharmaceutical industry is a major growth driver. Increasing healthcare spending, rising disease prevalence, population growth, and greater health awareness are increasing demand for medicines and, consequently, pharmaceutical packaging. Glass is preferred because it provides strong protection and is resistant to moisture and air.
Technological advancements in pharmaceutical manufacturing are also creating opportunities. The development of advanced glass formulations, improved manufacturing processes, and packaging technologies is helping manufacturers enhance product safety and minimize contamination risks.
Trends
The adoption of new glass types to minimize pharmaceutical contamination is an important market trend. Boron-free pharmaceutical glass can provide more uniform chemistry and improved chemical durability. Manufacturers are also adopting technologies such as permanent engraving and advanced packaging designs to improve product identification and address counterfeiting concerns.
Restraints
The increasing adoption of alternative packaging materials, particularly plastics, may restrain market growth. Plastic packaging offers lightweight construction, flexibility, impact resistance, easy molding, and lower transportation costs. Plastic bottles and cartridges can also reduce the risk of accidental breakage compared with glass containers.
Impact of COVID-19
The COVID-19 pandemic increased the importance of pharmaceutical packaging because of the need for vaccines, medicines, and other healthcare products. Demand for vials, syringes, and other pharmaceutical glass containers increased as pharmaceutical companies expanded vaccine and treatment production. At the same time, supply-chain disruptions and manufacturing restrictions created challenges for packaging manufacturers. The pandemic also accelerated investments in pharmaceutical manufacturing and packaging capacity.
By product, the market is segmented into vials & ampoules, bottles, cartridges, and syringes. The bottles segment held the largest market share in 2025, supported by their chemical inertness, rigidity, and protective properties. Bottles are widely used for tablets, capsules, syrups, and ophthalmic products.
Vials and ampoules are expected to witness strong demand because they protect pharmaceutical products from atmospheric gases and contamination. Syringes and cartridges are also gaining importance due to increasing demand for injectable and self-administered pharmaceutical products.
By drug type, the market is divided into generic, branded, and biologic drugs. The generic segment is the fastest-growing drug type, supported by lower costs, government initiatives encouraging generic medicines, patent expirations, and increasing demand in developing economies. Biologic drugs are also supporting packaging demand because of their increasing use in chronic and autoimmune disease treatment.
North America dominated the market with a 33.6% share in 2025, supported by pharmaceutical industry expansion, high healthcare spending, and strong demand for pharmaceutical products. The U.S. is the major contributor to regional growth.
Europe is the second-largest market, with Germany, the U.K., and Italy contributing significantly. Government guidelines, pharmaceutical manufacturing, and healthcare investments are supporting demand.
Asia Pacific is witnessing strong growth due to increasing pharmaceutical manufacturing investments in China, Japan, and India. Expansion of pharmaceutical companies and rising healthcare demand are creating opportunities for glass packaging manufacturers.
Latin America is supported by a growing geriatric population, healthcare awareness, and favorable government policies, while the Middle East & Africa is benefiting from expanding pharmaceutical manufacturing capabilities and healthcare investments.
Competitive Landscape
The competitive landscape is fragmented, with leading companies focusing on product innovation, research and development, manufacturing expansion, acquisitions, and advanced pharmaceutical packaging technologies. Key companies include Corning Inc., Nipro Corporation, SCHOTT, Gerresheimer AG, SGD S.A., Stolzle-Oberglas, Bormioli Pharma, West Pharmaceutical Services, Shandong Medicinal Glass, Beatson Clark, and Sisecam Group.
Recent developments include Nipro Pharma's agreement with AstraZeneca for vaccine fill-and-finish manufacturing, Stoelzle Glass Group's acquisition of Anchor Hocking's Monaca facility, and SCHOTT's investment in a pharmaceutical tubing factory in China.
Report Coverage
The pharmaceutical glass packaging market report covers market size and forecast for 2025, 2026, and 2034, product and drug-type segmentation, regional analysis, market drivers, trends, restraints, COVID-19 impact, competitive landscape, company profiles, and key industry developments. The report also examines packaging technologies, materials, sterilization methods, and pharmaceutical applications.
Conclusion
The global pharmaceutical glass packaging market is projected to grow from USD 24.29 billion in 2025 to USD 26.94 billion in 2026 and reach USD 61.63 billion by 2034, at a CAGR of 10.90%. Growing pharmaceutical production, rising healthcare expenditure, increasing demand for generic and biologic medicines, and technological advancements in pharmaceutical glass are expected to drive market expansion. North America remains a leading market, while Asia Pacific presents substantial growth opportunities through expanding pharmaceutical manufacturing. Meanwhile, competition from lightweight and cost-effective plastic packaging remains a key challenge. Innovation in pharmaceutical glass technology, contamination prevention, and advanced packaging solutions is expected to shape the market through 2034.
ATTRIBUTES DETAILS
Segmentation
By Product
By Drug Type
By Geography